Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Senkus

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|March 17, 2005
A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)E Senkus-Konefka, R Dziadziuszko, E Bednaruk-Młyński, et al.
Pneumonologia I Alergologia Polska|January 1, 1994
[Analysis of prognostic factors for long term survival in patients with small cell lung cancer]E Senkus, J Jassem, H Karnicka-Młodkowska, et al.
Annals of Medicine|July 8, 2025
Maternal nitrate supplementation improves offspring cardiometabolic outcomes in obese pregnanciesKristi M Crowe-White, Katelyn E Senkus, Janie C DiNatale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2021
Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiADD Hodgson, Z Lai, S Dearden, et al.
BMC Nutrition|December 20, 2025
Daily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesityStephanie B Jilcott Pitts, Qiang Wu, Melissa N Laska, et al.
Scientific Reports|July 23, 2025
Functional mouth rinse containing inorganic nitrate and antioxidants bolsters the enterosalivary pathway and lowers blood pressure in Wistar ratsKatelyn E Senkus, Maria Azrad, Anneliese Bolland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)M De Santis, P J Wiechno, J Bellmunt, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimizationG Curigliano, L Marotti, C Barrios, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|March 17, 2005
A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)E Senkus-Konefka, R Dziadziuszko, E Bednaruk-Młyński, et al.
Pneumonologia I Alergologia Polska|January 1, 1994
[Analysis of prognostic factors for long term survival in patients with small cell lung cancer]E Senkus, J Jassem, H Karnicka-Młodkowska, et al.
Annals of Medicine|July 8, 2025
Maternal nitrate supplementation improves offspring cardiometabolic outcomes in obese pregnanciesKristi M Crowe-White, Katelyn E Senkus, Janie C DiNatale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2021
Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiADD Hodgson, Z Lai, S Dearden, et al.
BMC Nutrition|December 20, 2025
Daily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesityStephanie B Jilcott Pitts, Qiang Wu, Melissa N Laska, et al.
Scientific Reports|July 23, 2025
Functional mouth rinse containing inorganic nitrate and antioxidants bolsters the enterosalivary pathway and lowers blood pressure in Wistar ratsKatelyn E Senkus, Maria Azrad, Anneliese Bolland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)M De Santis, P J Wiechno, J Bellmunt, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimizationG Curigliano, L Marotti, C Barrios, et al.
Pageof 7